Obeticholic acid for the treatment of primary biliary cholangitis in adult patients: clinical utility and patient selection

被引:33
作者
Bowlus, Christopher L. [1 ]
机构
[1] Univ Calif Davis, Div Gastroenterol & Hepatol, 4150 5 St,PSSB 3500, Davis, CA 95817 USA
关键词
primary biliary cholangitis; nuclear receptors; farnesoid X receptor; bile acid; obeticholic acid; ursodeoxycholic acid;
D O I
10.2147/HMER.S91709
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Primary biliary cholangitis (PBC), previously known as primary biliary "cirrhosis", is a rare autoimmune liver disease characterized by the hallmark autoantibodies to mitochondrial antigens and immune-mediated destruction of small bile duct epithelial cells leading to cholestasis and cirrhosis. Surprisingly, while immune modulators have not been effective in the treatment of PBC, supplementation with the hydrophilic bile acid (BA) ursodeoxycholic acid (UDCA) has been demonstrated to slow the disease progression. However, a significant minority of PBC patients do not have a complete response to UDCA and remain at risk of continued disease progression. Although the mechanisms of action are not well understood, UDCA provided proof of concept for BA therapy in PBC. Obeticholic acid (OCA), a novel derivative of the human BA chenodeoxycholic acid, is a potent agonist of the nuclear hormone receptor farnesoid X receptor, which regulates BA synthesis and transport. A series of clinical trials of OCA in PBC, primarily in combination with UDCA, have established that OCA leads to significant reductions in serum alkaline phosphatase that are predicted to lead to improved clinical outcomes, while dose-dependent pruritus has been the most common adverse effect. On the basis of these studies, OCA was given conditional approval by the US Food and Drug Administration with plans to establish the long-term clinical efficacy of OCA in patients with advanced PBC.
引用
收藏
页码:89 / 95
页数:7
相关论文
共 38 条
[1]
Adorin L., 2014, EASL MON PBC MAY 23
[2]
[Anonymous], PHAS 3 STUD OB AC EV
[3]
[Anonymous], 2016, OCALIVA R OB AC
[4]
Biochemical response to ursodeoxycholic acid predicts long-term outcome in Japanese patients with primary biliary cirrhosis [J].
Azemoto, Nobuaki ;
Kumagi, Teru ;
Abe, Masanori ;
Konishi, Ichiro ;
Matsuura, Bunzo ;
Hiasa, Yoichi ;
Onji, Morikazu .
HEPATOLOGY RESEARCH, 2011, 41 (04) :310-317
[5]
The diagnosis of primary biliary cirrhosis [J].
Bowlus, Christopher L. ;
Gershwin, M. Eric .
AUTOIMMUNITY REVIEWS, 2014, 13 (4-5) :441-444
[6]
Sex and Age Are Determinants of the Clinical Phenotype of Primary Biliary Cirrhosis and Response to Ursodeoxycholic Acid [J].
Carbone, Marco ;
Mells, George F. ;
Pells, Greta ;
Dawwas, Muhammad F. ;
Newton, Julia L. ;
Heneghan, Michael A. ;
Neuberger, James M. ;
Day, Darren B. ;
Ducker, Samantha J. ;
Sandford, Richard N. ;
Alexander, Graeme J. ;
Jones, David E. J. .
GASTROENTEROLOGY, 2013, 144 (03) :560-+
[7]
Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis [J].
Chen, Richy C. Y. ;
Naiyanetr, Phornnop ;
Shu, Shang-An ;
Wang, Jinjun ;
Yang, Guo-Xiang ;
Kenny, Thomas P. ;
Guggenheim, Kathryn C. ;
Butler, Jeffrey D. ;
Bowlus, Christopher ;
Tao, Mi-Hua ;
Kurth, Mark J. ;
Ansari, Aftab A. ;
Kaplan, Marshall ;
Coppel, Ross L. ;
Lleo, Ana ;
Gershwin, M. Eric ;
Leung, Patrick S. C. .
HEPATOLOGY, 2013, 57 (04) :1498-1508
[8]
The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis [J].
Corpechot, C ;
Carrat, F ;
Bahr, A ;
Chrétien, Y ;
Poupon, RE ;
Poupon, R .
GASTROENTEROLOGY, 2005, 128 (02) :297-303
[9]
Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis [J].
Corpechot, Christophe ;
Abenavoli, Ludovico ;
Rabahi, Nabila ;
Chretien, Yves ;
Andreani, Tony ;
Johanet, Catherine ;
Chazouilleres, Olivier ;
Poupon, Raoul .
HEPATOLOGY, 2008, 48 (03) :871-877
[10]
Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome [J].
Corpechot, Christophe ;
Chazouilleres, Olivier ;
Poupon, Raoul .
JOURNAL OF HEPATOLOGY, 2011, 55 (06) :1361-1367